Metabolites of the kynurenine pathway of tryptophan metabolism in the cerebrospinal fluid of Malawian children with malaria

Journal of Infectious Diseases

Volumn 188, Issue 6, 2003, Pages 844-849

  Medana, Isabelle M ^a   Day, Nicholas P J ^a   Salahifar Sabet, Houta ^c,g   Stocker, Roland ^c   Smythe, George ^c   Bwanaisa, Lloyd ^e   Njobvu, Alfred ^e   Kayira, Kondwani ^e   Turner, Gareth D H ^a,b   Taylor, Terrie E ^e,f   Hunt, Nicholas H ^d  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e UNIVERSITY OF MALAWI   (Malawi)

^f MICHIGAN STATE UNIVERSITY   (United States)

^g UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KYNURENIC ACID; KYNURENINE; PICOLINIC ACID; QUINOLINIC ACID;

ARTICLE; BRAIN DEVELOPMENT; BRAIN MALARIA; CEREBROSPINAL FLUID; CHILD; CONTROLLED STUDY; CONVULSION; DISEASE ASSOCIATION; FEMALE; HISTORY OF MEDICINE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NERVE DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME; TRYPTOPHAN METABOLISM;

ADULT; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; HUMANS; KYNURENINE; MALARIA, CEREBRAL; MALAWI; PICOLINIC ACIDS; QUINOLINIC ACID; RETROSPECTIVE STUDIES; TRYPTOPHAN; VIETNAM;

EID: 0141840758     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/377583     Document Type: Article

References (25)

1. Turner GDH. Cerebral malaria. Brain Pathol 1997; 7:569-82.
2. Newton CR, Hien TT, White N. Cerebral malaria. J Neurol Neurosurg Psychiatry 2000; 69:433-41.
3. Brown H, Hien TT, Dav N, et al. Evidence of blood-brain barrier dysfunction in human cerebral malaria. Neuropathol Appl Neurobiol 1999; 25:331-40.
4. Brown HC, Chau TT, Mai NT, et al. Blood-brain barrier function in cerebral malaria and CNS infections in Vietnam. Neurology 2000; 55:104-11.
5. Brown H, Rogerson S, Taylor T, et al. Blood-brain barrier function in cerebral malaria in Malawian children. Am J Trop Med Hyg 2001; 64:207-13.
6. Dobbie M, Crawley J, Waruiru C, Marsh K, Surtees R. Cerebrospinal fluid studies in children with cerebral malaria: an excitotoxic mechanism? Am J Trop Med Hyg 2000; 62:284-90.
7. Medana IM, Hien TT, Day NP, et al. The clinical significance of cerebrospinal fluid levels of kynurenine pathway metabolites and lactate in severe malaria. J Infect Dis 2002; 185:650-6.
8. Sanni LA, Thomas SR, Tattam BN, et al. Dramatic changes in oxidative tryptophan metabolism along the kynurenine pathway in experimental cerebral and noncerebral malaria. Am J Pathol 1998; 152:611-9.
9. Beninger RJ, Colton AM, Ingles JL, Jhamandas K, Boegman RJ. Picolinic acid blocks the neurotoxic but not the neuroexcitant properties of quinolinic acid in the rat brain: evidence from turning behaviour and tyrosine hydroxylase immunohistochemistry. Neuroscience 1994; 61:603-12.
10. Stone TW. Neuropharmacology of quinolinic and kynurenic acids. Pharmacol Rev 1993; 45:309-79.
11. Stone TW. Kynurenines in the CNS: from endogenous obscurity to therapeutic importance. Prog Neurobiol 2001; 64:185-218.
12. Heyes MP, Saito K, Crowley JS, et al. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease. Brain 1992; 115:1249-73.
13. Bosco MC, Rapisarda A, Massazza S, Melillo G, Young H, Varesio L. The tryptophan catabollte picolinic acid selectively induces the chemokines macrophage inflammatory protein-1α and -1β in macrophages. J Immunol 2000; 164:3283-91.
14. Pais TF, Appelberg R. Macrophage control of mycobacterial growth induced by picolinic acid is dependent on host cell apoptosis. J Immunol 2000; 164:389-97.
15. Batshaw ML, Robinson MB, Hyland K, Djali S, Heyes MP. Quinolinic acid in children with congenital hyperammonemia. Ann Neurol 1993; 34:676-81.
16. Smythe GA, Braga O, Brew BJ, et al. Concurrent quantification of quinolinic, picolinic, and nicotinic acids using electron-capture negative-ion gas chromatography-mass spectrometry. Anal Biochem 2002; 301:21-6.
17. Saito K, Fujigaki S, Heyes MP, et al. Mechanism of increases in L-kynurenine and quinolinic acid in renal insufficiency. Am J Physiol Renal Physiol 2000; 279:F565-72.
18. Mishra PO, Fritz KL, Delivoria-Papadoulos M. NMDA receptor and neonatal hypoxic brain injury. Ment Retard Dev Disabil Res Rev 2001; 7:249-53.
19. Sanchez RM, Jensen FE. Maturational aspects of epilepsy mechanisms and consequences for the immature brain. Epilepsia 2001; 42:577-85.
20. Baran H, Kepplinger B, Herrera-Marschitz M, Stolze K, Lubec G, Nohl H. Increased kynurenic acid in the brain after neonatal asphyxia. Life Sci 2001; 69:1249-56.
21. Ceresoli-Borroni G, Schwarcz R. Neonatal asphyxia in rats: acute effects on cerebral kynurenine metabolism. Pediatr Res 2001; 50:231-5.
22. Baran H, Gramer M, Honack D, Loscher W. Systemic administration of kainate induces marked increases of endogenous kynurenic acid in various brain regions and plasma of rats. Eur J Pharmacol 1995; 286:167-75.
23. Baran H, Jellinger K, Deecke L. Kynurenine metabolism in Alzheimer's disease. J Neural Transm 1999; 106:165-81.
24. Holding PA, Snow RW. Impact of Plasmodium falciparum malaria on performance and learning: review of the evidence. Am J Trop Med Hyg 2001; 64:68-75.
25. Holding PA, Stevenson J, Peshu N, Marsh K. Cognitive sequelae of severe malaria with impaired consciousness. Trans R Soc Trop Med Hyg 1999; 93:529-34.